Xin Hua She·2025-08-20 23:41Core Insights - The Chinese government emphasizes the importance of accelerating the development of the biopharmaceutical industry, focusing on high-quality technological supply and policy support to enhance innovation and produce more effective drugs [1][2] Group 1: Government Initiatives - The government aims to strengthen original innovation and tackle key core technologies in the biopharmaceutical sector, leveraging both government and market resources to foster innovation [2] - There is a significant market potential in the health industry, with a focus on identifying innovative drug projects with high clinical value and transformation potential [1][2] Group 2: Research and Development - The government encourages collaborative research efforts targeting new drug targets, compounds, and mechanisms, aiming to produce major original achievements and cultivate high-end talent in life sciences [1] - The establishment of shared research platforms is promoted to accelerate the transformation of biopharmaceutical innovations, providing comprehensive support for the entire research and development cycle [2] Group 3: Industry Collaboration - The government advocates for deepening international cooperation among enterprises to enhance innovation and competitiveness in the biopharmaceutical sector [1] - There is a call for optimizing the operational models of innovation platforms to create replicable and scalable practices [2]